P-198: Real-life experience of the combination of daratumumab, bortezomib, melphalan, and prednisone (DVMP) in patients with newly diagnosed multiple myeloma ineligible for autologous stem cell transplantation

Autor: Domingo-González, Amalia, Alonso, Rafael, de Soto Álvarez, Teresa, Lerma, Ana, Moro, Fernando Martín, Sánchez-Pina, Jose, Fernández, Virginia Pradillo, Landete, Elena, Valdazo, Alberto E. Velasco, Cuevas, Marina Menéndez, Riñón, Mónica María López, López, Andrés Ramírez, López-García, Alberto, del Campo, Paula Lázaro, Gómez, Fabio Augusto Ruiz, Blanchard, María Jesús, Askari, Elham
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia August 2022 22 Supplement:S144-S144
Databáze: ScienceDirect
Externí odkaz: